A5072084706- Pharmaceutical Economics and Policy
- Pharmaceutical Practices and Patient Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical studies and practices
- Biosimilars and Bioanalytical Methods
- Healthcare Policy and Management
- Pharmaceutical industry and healthcare
- Nausea and vomiting management
- Antibiotic Use and Resistance
- Colorectal Cancer Treatments and Studies
- Health Sciences Research and Education
- Chronic Lymphocytic Leukemia Research
- Ethics in Clinical Research
- Medication Adherence and Compliance
- Healthcare cost, quality, practices
- Immunodeficiency and Autoimmune Disorders
- Venous Thromboembolism Diagnosis and Management
- Patient Safety and Medication Errors
- Sympathectomy and Hyperhidrosis Treatments
- Anesthesia and Sedative Agents
- Health Policy Implementation Science
- Clinical practice guidelines implementation
- HER2/EGFR in Cancer Research
- Health and Medical Research Impacts
- Helicobacter pylori-related gastroenterology studies
American Association of Colleges of Pharmacy
2023-2025
University of Kentucky
1969-2021
University of Kentucky HealthCare
2017-2021
University of Wisconsin–Madison
2007-2016
University of Wisconsin Health
2011-2016
University of Wisconsin System
2016
UW Health University Hospital
2003-2015
National Bureau of Economic Research
2011
Congressional Budget Office
2011
Mathematica Policy Research
2011
Consumers need information to compare alternatives for markets function efficiently. Recognizing this, public policies often pair competition with easy access comparative information. The implicit assumption is that comparison friction—the wedge between the availability of and consumers' use it—is inconsequential because when readily available, consumers will this make effective choices. We examine extent friction in market Medicare Part D prescription drug plans United States. In a...
These guidelines outline the recommended processes and techniques for formulary system management describe pharmacist’s responsibilities roles in managing partnership with other health care professionals. also provide assistance to pharmacists
The objectives of this effort were to summarize and critique original economic assessments clinical pharmacy services published from 1988–1995, make recommendations for future work in area. A literature search was conducted identify articles that then blinded randomly assigned reviewers confirm inclusion, abstract information, assess the quality study design. 104 fell into four main categories based on type service described: disease state management (4%), general pharmacotherapeutic...
<h3>Objective:</h3> To develop contemporary, comprehensive guidelines for the appropriate and efficient use of albumin, nonprotein colloid, crystalloid solutions. <h3>Design:</h3> A systematic, literature-based, consensus exercise employing a modified Delphi method. <h3>Participants:</h3> Thirty-one medical allied health professionals from 26 University Hospital Consortium (Oak Brook, Ill) member institutions were initially chosen to participate. Participants selected on basis their...
The objectives of this review were to summarize and evaluate studies that measured the economic impact clinical pharmacy services published between 2001 2005 (inclusive) provide guidance on methodologic considerations individuals performing such research in future. A systematic literature search using MEDLINE International Pharmaceutical Abstracts databases was conducted identify evaluations services. Studies screened then randomly assigned reviewers, who reassessed inclusion exclusion...
Factors likely to influence drug expenditures, expenditure trends in 2010 and 2011, projected expenditures for 2012 are discussed.Data were analyzed provide total the hospital clinic sectors. Data obtained from IMS Health National Sales Perspectives database. From 2009 2010, U.S. increased by 2.7%, with spending rising $299.2 billion $307.5 billion. Drug clinics grew 6.0% 2010. Hospital at moderate rate of 1.5% 2010; through first nine months only 0.3% compared same period The dominant trend...
An analysis of trends in U.S. pharmaceutical spending is presented, including projections for drug expenditures nonfederal hospital and clinic settings 2014.Trends developments likely to influence future spending, new approvals patent expirations, were analyzed using data from the IMS Health National Sales Perspectives database. Projections based on a combination quantitative qualitative analyses expert opinion.Total prescription sales 12 months ending September 2013 approximately $326...
Historical trends and factors likely to influence future pharmaceutical expenditures are discussed, projections made for drug spending in 2017 nonfederal hospitals, clinics, overall (all sectors).Drug expenditure data through calendar year 2016 were obtained from the QuintilesIMS National Sales Perspectives database analyzed. Other that may hospitals clinics 2017, including new approvals patent expirations, also reviewed. Expenditure sectors) based on a combination of quantitative analyses...
Abstract Purpose To report historical patterns of pharmaceutical expenditures, to identify factors that may influence future spending, and predict growth in drug spending 2020 the United States, with a focus on nonfederal hospital clinic sectors. Methods Historical were assessed by examining data purchases from manufacturers using IQVIA National Sales Perspectives database. Factors hospitals clinics reviewed, including new approvals, patent expirations, potential policies or legislation....
Surveys conducted in our healthcare facility evaluated factors associated with acceptance of influenza vaccination and opinions regarding prevention treatment willingness to pay. Avoiding lost work low risk were primary reasons for vaccine recipients non-recipients, respectively. One-third would refuse if asked pay at least $10.
The current state of hospital pharmacy practice around the globe and key issues facing international were studied.This survey assessed multiple aspects within each Member States recognized by United Nations. An official respondent from nation was identified a structured nomination process. instrument developed; pilot tested; translated into English, French, Spanish; distributed in July 2007. nature, scope, breadth practices medication procurement, prescribing, preparation distribution,...
Abstract Purpose Historical trends and factors likely to influence future pharmaceutical expenditures are discussed, projections made for drug spending in 2019 nonfederal hospitals, clinics, overall (all sectors). Methods Drug expenditure data through calendar year 2018 were obtained from the IQVIA National Sales Perspectives database analyzed. New approvals, patent expirations, other that may hospitals clinics also reviewed. Expenditure sectors) a combination of quantitative analyses expert...
The impact of drug shortages on patient care, the resources used to manage shortages, and cost associated with were studied.A national online survey was conducted quantify effects care pharmacy expenses. Directors in acute institutions ASHP member database asked estimate acquisition costs, pharmacist nonpharmacist staff time dedicated specific functions related drug-compounding expenses.Usable responses received from 370 (24.7%) 1496 directors. Nearly all directors surveyed believed that had...
This publication is an update of the American College Clinical Pharmacy (ACCP) Position Statement on "Guidelines for Therapeutic Interchange," 1 originally published in 1993.The ACCP supports practice therapeutic interchange, which pharmacists collaborate with physicians and other health care professionals to develop policies implement programs that improve drug use provide best possible patient at most affordable cost.The has established following guidelines implementing interchange...
An analysis of trends in U.S. pharmaceutical spending is presented, including projections for drug expenditures nonfederal hospital and clinic settings 2015.Prescription expenditure data through September 2014 were obtained from the IMS Health National Sales Perspectives database analyzed descriptively. Other factors that may influence prescription hospitals clinics 2015, new approvals patent expirations, analyzed. Expenditure based on a combination quantitative qualitative analyses expert...
Drug expenditure trends in 2007 and 2008, projected drug expenditures for 2009, factors likely to influence are discussed.Various including drugs development, the diffusion of new drugs, safety concerns, generic Medicare Part D, changes supply chain. The increasing availability important concerns continue moderate growth expenditures. chain remains dynamic may expenditures, particularly specialized therapeutic areas. Initial data suggest that D benefit has influenced but ultimate impact on...
Drug expenditure trends in 2009 and 2010, projected drug expenditures for 2011, factors likely to influence are discussed. Various including drugs development, the diffusion of new drugs, generic health care reform, biosimilars. Two distinct patterns continue exist. The dominant trend over past several years is substantial moderation growth widely used primarily due ongoing introduction medications high-cost, frequently economic downturn. second pattern increases specialized medications,...
Historical trends and factors likely to influence future pharmaceutical expenditures are discussed, projections made for drug spending in 2018 nonfederal hospitals, clinics, overall (all sectors).Drug expenditure data through calendar year 2017 were obtained from the IQVIA (formerly QuintilesIMS) National Sales Perspectives database analyzed. New approvals, patent expirations, other that may hospitals clinics also reviewed. Expenditure sectors) based on a combination of quantitative analyses...
The high-value pharmacy enterprise (HVPE) framework and constituent best practice consensus statements are presented, the methods used to develop framework's 8 domains described. A panel of leaders an evidence- expert opinion-based approach define core aspirational elements that should be established within contemporary health-system enterprises by calendar year 2025. Eight HVPE were identified: Patient Care Services; Business Ambulatory Specialty Pharmacy Inpatient Operations; Safety...